Diabetes

The latest diabetes and endocrinology news from UNC Health Care and the UNC School of Medicine.

UNC researchers featured in PCORI, ADA video for international conference

UNC researchers featured in PCORI, ADA video for international conference

Katrina Donahue, MD, MPH, in the department of family medicine and Laura Young, MD, PhD, and John Buse, MD, PhD, in the department of medicine were featured in this American Diabetes Association video about the MONITOR Trial and a $1.3 million PCORI-funded effort to translate UNC diabetes research into the clinic.

UNC researchers featured in PCORI, ADA video for international conference - Read More…

Kirkman Publishes NIH Blog on National Trends in Diabetes Knowledge, Perceptions, and Behaviors

Kirkman Publishes NIH Blog on National Trends in Diabetes Knowledge, Perceptions, and Behaviors

Findings from a national survey reveal that we are seeing some improvements in diabetes awareness and knowledge, but more work is needed to improve diabetes-related health care and education.

Kirkman Publishes NIH Blog on National Trends in Diabetes Knowledge, Perceptions, and Behaviors - Read More…

Lorenzo earns ADA junior faculty award

Lorenzo earns ADA junior faculty award

The American Diabetes Association selected Damaris Lorenzo, PhD, as a winner of its Junior Faculty Development Award, which carries with it funding for further research on diabetes-related investigations.

Lorenzo earns ADA junior faculty award - Read More…

School of Medicine Researchers Make International Highly Cited Research List

School of Medicine Researchers Make International Highly Cited Research List

Fourteen UNC School of Medicine faculty members were listed by Clarivate Analytics in the company’s 2018 Highly Cited Research list.

School of Medicine Researchers Make International Highly Cited Research List - Read More…

UNC researchers awarded $1.3 million to put diabetes discovery into practice across the U.S.

UNC researchers awarded $1.3 million to put diabetes discovery into practice across the U.S.

A landmark UNC School of Medicine study showed that the finger prick blood glucose test is unnecessary for most people with type 2 diabetes, and now researchers Katrina Donahue and Laura Young received a PCORI grant to implement their findings across the country.

UNC researchers awarded $1.3 million to put diabetes discovery into practice across the U.S. - Read More…

UNC research, diabetes expertise featured in video at international conference

UNC research, diabetes expertise featured in video at international conference

The American Diabetes Association featured UNC-Chapel Hill diabetes experts and leaders in a video presented at the ADA's 78th Scientific Sessions this summer.

UNC research, diabetes expertise featured in video at international conference - Read More…

Kirkman to chair National Diabetes Education Program

Kirkman to chair National Diabetes Education Program

M. Sue Kirkman, MD, Professor of Medicine and Medical Director of the UNC Diabetes Care Center's Clinical Trials Unit, has been appointed Chair of the National Diabetes Education Program. Kirkman's term as Chair begins on Jan. 1, 2018.

Kirkman to chair National Diabetes Education Program - Read More…

Buse leads clinical trial of new type 1 diabetes treatment

Buse leads clinical trial of new type 1 diabetes treatment

The study is designed to evaluate whether TTP399 is well tolerated when administered as an add-on to insulin therapy and can improve daily glucose profiles and HbA1c in people living with type 1 diabetes.

Buse leads clinical trial of new type 1 diabetes treatment - Read More…

Smart Artificial Beta Cells Could Lead to New Diabetes Treatment

Smart Artificial Beta Cells Could Lead to New Diabetes Treatment

In lab experiments and animal models, UNC and NC State researchers led by Zhen Gu, PhD, designed synthetic beta cells to secrete insulin in response to high blood sugar.

Smart Artificial Beta Cells Could Lead to New Diabetes Treatment - Read More…

UNC/NC State spinout company raises $5.8M for ‘smart’ insulin devices

UNC/NC State spinout company raises $5.8M for ‘smart’ insulin devices

A Research Triangle Park startup founded by Zhen Gu, PhD, a biomedical engineer with joint faculty appointments at UNC and NC State University received a $5.8 million cash infusion to continue translation efforts of ‘smart’ insulin devices.

UNC/NC State spinout company raises $5.8M for ‘smart’ insulin devices - Read More…

UNC co-leads large clinical trial on new combo therapy for type 2 diabetes

UNC co-leads large clinical trial on new combo therapy for type 2 diabetes

New insulin degludec has comparable cardiovascular safety rates to insulin glargine U100 but with less risk of triggering low blood sugar.

UNC co-leads large clinical trial on new combo therapy for type 2 diabetes - Read More…

Is the finger-stick blood test necessary for type 2 diabetes treatment?

Is the finger-stick blood test necessary for type 2 diabetes treatment?

In the first large pragmatic trial of its kind in the United States, results from a UNC School of Medicine study show that checking finger-stick blood sugars may not help diabetes patients who do not use insulin.

Is the finger-stick blood test necessary for type 2 diabetes treatment? - Read More…

Researchers implicate suspect in heart disease linked to diabetes

Researchers implicate suspect in heart disease linked to diabetes

In their study of the IRS-1 protein, researchers at the University of North Carolina found a new lead for reversing or preventing heart disease associated with diabetes.

Researchers implicate suspect in heart disease linked to diabetes - Read More…

UNC clinical trials play crucial role in FDA approval for diabetes drug

UNC clinical trials play crucial role in FDA approval for diabetes drug

Led by John Buse, MD, PhD, director of the UNC Diabetes Care Center, the clinical research of UNC doctors and the participation of thousands of patients culminates in a new, effective, and safe daily injectable drug to combat type-2 diabetes.

UNC clinical trials play crucial role in FDA approval for diabetes drug - Read More…

Diabetes drug lowers risk of cardiovascular complications, kidney disease

Diabetes drug lowers risk of cardiovascular complications, kidney disease

For the first time, a large clinical trial showed across-the-board cardiovascular benefit of a diabetes drug – liraglutide – a much-needed outcome for people with type 2 diabetes.

Diabetes drug lowers risk of cardiovascular complications, kidney disease - Read More…

UNC diabetes expert John Buse featured twice on WRAL

UNC diabetes expert John Buse featured twice on WRAL

Buse led a global clinical trial on the new type-2 diabetes drug iDegLira, and he spoke to the local news station about the best ways to screen for the disease.

UNC diabetes expert John Buse featured twice on WRAL - Read More…

Scientists create painless patch of insulin-producing beta cells to control diabetes

Scientists create painless patch of insulin-producing beta cells to control diabetes

The new “smart cell patch” developed at UNC and NC State is a proof of principle to treat millions of people with type-1 and advanced type-2 diabetes.

Scientists create painless patch of insulin-producing beta cells to control diabetes - Read More…

New type-2 diabetes therapy proves better than traditional insulin injections

New type-2 diabetes therapy proves better than traditional insulin injections

UNC-led global phase-3 clinical trial sets the stage for improved management of a disease that affects nearly 30 million Americans.

New type-2 diabetes therapy proves better than traditional insulin injections - Read More…

Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship

Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship

The joint UNC/NC State researcher also earned a grant from JDRF and Sanofi to further develop glucose responsive insulin therapies for diabetes.

Biomedical engineer Zhen Gu receives prestigious Sloan Fellowship - Read More…

Share This: